Adaptimmune’s Post

Step Pharma was founded in 2014 based on the science of Professor Alain Fischer at the Imagine Institute in Paris. By characterising CTPS1 mutations in children, Professor Fischer and his team laid the foundations for understanding the role of CTPS1 in both malignant and normal cell proliferation.    Find out more about how Step Pharma was created from this groundbreaking discovery by Professor Alain Fischer.    #CTPS1 #oncology #drugdiscovery 

Heading to #ASCO? Come meet me at booth 13059 to learn about how Tempus MultiOmics accelerates drug discovery. #personalizedmedicine #oncology #multiomics

This white paper reviews the current immuno-oncology landscape and offers guidance for biotech companies preparing for IO studies, including cell- and gene-based therapies. https://bit.ly/3WpobLV #oncology #immunooncology #clinicalresearch #immunotherapy #biotech #genetherapy #CAGT #celltherapy #clinicaltrials

📈 💊 Would you like to reduce market entry by over one year? Integrate your multi-omics data for faster analysis and accelerated clinical trials. We helped an immunotherapy company integrate their multi-omic data from multiple studies, reducing analysis time from 6 months to 5 weeks and accelerating market entry by over a year. Read Case Study: https://bit.ly/4evT08n #Sonrai #AI #Innovation #PrecisionMedicine #Oncology #Biopharma #DataAnalytics #MultiOmics #SonraiDiscovery #SonraiAnalytics

Our #medical teams work tirelessly to deliver #research and insights to key stakeholders for the advancement of #clinicaloncology. On the heels of #WorldCancerDay, we are proud to continue delivering on our promise of clinical advancement. KCR CMO Anna Baran and Principal Consultant, Dave Li, recently published an article in pharmaphorum - highlighting roadblocks to the development of predictive #biomarkers and offering a path towards more effective study designs for #data collection and analysis. Check it out! #KCRCRO #BostonBiotech #KCRSolutions #WCD #WorldCancerDay #oncology

Exploring RAS and RAF Target Engagement: Live-Cell Insights into Molecular Specificity 🔎 Check out a new #PromegaNotes article to discover advanced assay technologies, such as live-cell #NanoBRET® TE Intracellular Assays, reshaping the landscape of drug discovery methods and offering biologically relevant models for enhanced research. https://bit.ly/3zEFa3O #CancerResearch #oncology #lifescience

Download the white paper “Excellence in Immuno-Oncology Clinical Trials” to learn how to reduce risk and plan for success. This paper offers insights on how to navigate the top operational challenges of IO clinical development, including diversity planning. https://bit.ly/49W0Vcb #oncology #immunooncology #clinicalresearch #immunotherapy #biotech #genetherapy #CAGT #celltherapy #clinicaltrials

📈 💊 Would you like to reduce market entry by over one year? Integrate your multi-omics data for faster analysis and accelerated clinical trials. We helped an immunotherapy company integrate their multi-omic data from multiple studies, reducing analysis time from 6 months to 5 weeks and accelerating market entry by over a year. Read Case Study: https://bit.ly/4evT08n #Sonrai #AI #Innovation #PrecisionMedicine #Oncology #Biopharma #DataAnalytics #MultiOmics #SonraiDiscovery #SonraiAnalytics

As we approach the end of an incredible #ESMO23 in Madrid, we reflect on the countless insightful meetings and engaging conferences we've attended.    It's been a whirlwind of collaboration, knowledge-sharing, and innovation in the world of oncology.   We're already looking forward to ESMO2024. Until then, let's keep pushing the boundaries of what's possible in clinical research.    #clinicalresearch #biotech #oncology